Kalaris Therapeutics Appoints Liisa Bayko as New Chief Financial Officer
Liisa Bayko, MBA.BERKELEY HEIGHTS, N.J.—Kalaris Therapeutics, Inc. (Nasdaq: KLRS), a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for common retinal diseases has announced the appointment of…
